Agilon End Period Cash Flow from 2010 to 2024
| AGL Stock | USD 2.26 0.37 19.58% |
End Period Cash Flow | First Reported 2018-12-31 | Previous Quarter 116.3 M | Current Value 153.8 M | Quarterly Volatility 378.1 M |
Check Agilon Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Agilon Health's main balance sheet or income statement drivers, such as Tax Provision of 936.1 K, Interest Income of 5.6 M or Discontinued Operations of 561.5 K, as well as many indicators such as Price To Sales Ratio of 1.13, Dividend Yield of 0.0 or PTB Ratio of 8.14. Agilon financial statements analysis is a perfect complement when working with Agilon Health Valuation or Volatility modules.
Agilon | End Period Cash Flow |
Latest Agilon Health's End Period Cash Flow Growth Pattern
Below is the plot of the End Period Cash Flow of agilon health over the last few years. It is Agilon Health's End Period Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Agilon Health's overall financial position and show how it may be relating to other accounts over time.
| End Period Cash Flow | 10 Years Trend |
|
End Period Cash Flow |
| Timeline |
Agilon End Period Cash Flow Regression Statistics
| Arithmetic Mean | 225,377,103 | |
| Geometric Mean | 173,729,086 | |
| Coefficient Of Variation | 110.27 | |
| Mean Deviation | 148,232,772 | |
| Median | 145,612,000 | |
| Standard Deviation | 248,524,992 | |
| Sample Variance | 61764.7T | |
| Range | 946.2M | |
| R-Value | 0.32 | |
| Mean Square Error | 59700T | |
| R-Squared | 0.10 | |
| Significance | 0.24 | |
| Slope | 17,789,024 | |
| Total Sum of Squares | 864705.4T |
Agilon End Period Cash Flow History
About Agilon Health Financial Statements
Agilon Health investors utilize fundamental indicators, such as End Period Cash Flow, to predict how Agilon Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| End Period Cash Flow | 114.3 M | 108.6 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of Agilon Health Correlation against competitors. For more information on how to buy Agilon Stock please use our How to buy in Agilon Stock guide.You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Agilon Health. If investors know Agilon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Agilon Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 11.951 | Earnings Share (0.76) | Revenue Per Share 13.717 | Quarterly Revenue Growth 0.276 | Return On Assets (0.1) |
The market value of agilon health is measured differently than its book value, which is the value of Agilon that is recorded on the company's balance sheet. Investors also form their own opinion of Agilon Health's value that differs from its market value or its book value, called intrinsic value, which is Agilon Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Agilon Health's market value can be influenced by many factors that don't directly affect Agilon Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Agilon Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Agilon Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Agilon Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.